Therapeutic Challenges and Outcomes in Scarring Alopecia: A Retrospective Study in Singapore
International Journal of Trichology · 2025-09 · 17 (5) · 391-398
DOI: 10.4103/ijt.ijt_48_25 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Trichology, online erschienen am 12.08.2026. Verfasst von Chenghao Huang und 5 weiteren Autor:innen. Die Arbeit nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background
Scarring alopecia comprises a heterogeneous group of disorders, characterized by irreversible follicular destruction and permanent hair loss. This retrospective study examines the clinical characteristics and therapeutic outcomes of primary scarring alopecias managed at the National Skin Center, Singapore, from 2004 to 2020.
Methods
Medical records of 300 patients diagnosed with discoid lupus erythematosus (DLE), frontal fibrosing alopecia (FFA), lichen planopilaris (LPP), folliculitis decalvans (FD), acne keloidalis (AK), dissecting cellulitis of the scalp (DCS), and pseudopelade of brocq (PoB) were reviewed.
Results
Notably, classic LPP showed a disproportionately high prevalence among ethnic Indians (54.6%) compared to FFA (9.0%). This aligns with existing reports of increased lichen planus (LP) incidence in this population and suggests a stronger pathophysiological link between LPP and LP than between FFA and LP. Among lymphocytic variants (LPP, FFA, DLE, and PoB), 77.7% (212/273) of treatments achieved stabilization or improvement, with 6% showing marked improvement. Neutrophilic variants (FD, DCS) responded more favorably, with 81.5% (172/211) achieving positive outcomes, including 21.8% reporting improvement. Mixed scarring alopecia (AK) had the highest treatment response (85.5% stabilized, 26.5% improved). Isotretinoin demonstrated superior efficacy for neutrophilic alopecias compared to oral antibiotics, although the use was limited by adverse effects. FFA showed strong responses to topical corticosteroids (88.9%) and finasteride (83.3%). Systemic agents such as hydroxychloroquine and immunosuppressants improved the outcomes in severe lymphocytic cases.
Conclusions
This study underscores the heterogeneity of scarring alopecias and highlights better treatment responses in neutrophilic and mixed variants. Early diagnosis and individualized therapy remain critical to optimizing patient outcomes.
Zitieren
APA
Huang, C., Foo, H. L., Tan, F., Wang, C. E. E., Yuan, W. D., & Lee, S. S. J. (2025). Therapeutic Challenges and Outcomes in Scarring Alopecia: A Retrospective Study in Singapore. International Journal of Trichology, 17(5), 391-398. https://doi.org/10.4103/ijt.ijt_48_25
Vancouver
Huang C, Foo HL, Tan F, Wang CEE, Yuan WD, Lee SSJ. Therapeutic Challenges and Outcomes in Scarring Alopecia: A Retrospective Study in Singapore. International Journal of Trichology. 2025;17(5):391-398. doi:10.4103/ijt.ijt_48_25
BibTeX
@article{Huang2025,
author = {Huang, Chenghao and Foo, Hui Ling and Tan, Faith and Wang, Cho Ee Etienne and Yuan, Wang Ding and Lee, Siong See Joyce},
title = {Therapeutic Challenges and Outcomes in Scarring Alopecia: A Retrospective Study in Singapore},
journal = {International Journal of Trichology},
year = {2025},
volume = {17},
number = {5},
pages = {391--398},
doi = {10.4103/ijt.ijt_48_25}
}
EUVIMED